ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population
- PMID: 38430457
- PMCID: PMC11007809
- DOI: 10.1111/jch.14785
ATP2B1 gene polymorphisms associated with resistant hypertension in the Japanese population
Abstract
Single-nucleotide polymorphisms (SNP) of ATP2B1 gene are associated with essential hypertension but their association with resistant hypertension (RHT) remains unexplored. The authors examined the relationship between ATP2B1 SNPs and RHT by genotyping 12 SNPs in ATP2B1 gene of 1124 Japanese individuals with lifestyle-related diseases. Patients with RHT had inadequate blood pressure (BP) control using three antihypertensive drugs or used ≥4 antihypertensive drugs. Patients with controlled hypertension had BP controlled using ≤3 antihypertensive drugs. The association between each SNP and RHT was analyzed by logistic regression. The final cohort had 888 (79.0%) and 43 (3.8%) patients with controlled hypertension and RHT, respectively. Compared with patients homozygous for the minor allele of each SNP in ATP2B1, a significantly higher number of patients carrying the major allele at 10 SNPs exhibited RHT (most significant at rs1401982: 5.8% vs. 0.8%, p = .014; least significant at rs11105378: 5.7% vs. 0.9%, p = .035; most nonsignificant at rs12817819: 5.1% vs. 10%, p = .413). After multivariate adjustment for age, sex, systolic BP, and other confounders, the association remained significant for rs2681472 and rs1401982 (OR: 7.60, p < .05 and OR: 7.62, p = .049, respectively). Additionally, rs2681472 and rs1401982 were in linkage disequilibrium with rs11105378. This study identified two ATP2B1 SNPs associated with RHT in the Japanese population. rs1401982 was most closely associated with RHT, and major allele carriers of rs1401982 required significantly more antihypertensive medications. Analysis of ATP2B1 SNPs in patients with hypertension can help in early prediction of RHT and identification of high-risk patients who are more likely to require more antihypertensive medications.
Keywords: ATP2B1 gene polymorphisms; Japanese; blood pressure; genotyping; resistant hypertension.
© 2024 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have no conflicts of interest.
Figures


Similar articles
-
Cochrane in context: pharmacological interventions for hypertension in children.Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975. Evid Based Child Health. 2014. PMID: 25236306
-
Pharmacological interventions for hypertension in children.Cochrane Database Syst Rev. 2014 Feb 1;2014(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Cochrane Database Syst Rev. 2014. PMID: 24488616 Free PMC article.
-
Pharmacological interventions for hypertension in children.Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974. Evid Based Child Health. 2014. PMID: 25236305
-
Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.Cochrane Database Syst Rev. 2016 Mar 10;3(3):CD007451. doi: 10.1002/14651858.CD007451.pub2. Cochrane Database Syst Rev. 2016. PMID: 26961574 Free PMC article.
-
Beta-blockers for hypertension.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. doi: 10.1002/14651858.CD002003.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002003. doi: 10.1002/14651858.CD002003.pub3. PMID: 17253471 Updated.
Cited by
-
Deciphering the Role of Calcium Signaling Pathway-Associated Single Nucleotide Variants in Susceptibility to Hypertension.J Clin Lab Anal. 2025 Feb;39(3):e25141. doi: 10.1002/jcla.25141. Epub 2025 Jan 16. J Clin Lab Anal. 2025. PMID: 39817473 Free PMC article.
References
-
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269‐1324. Erratum in: Hypertension e136‐e139. 2018;71. Erratum in: Hypertension 2018;72:e33. - PubMed
-
- Noubiap JJ, Nansseu JR, Nyaga UF, Sime PS, Francis I, Bigna JJ. Global prevalence of resistant hypertension: a meta‐analysis of data from 3.2 million patients. Heart. 2019;105:98‐105. - PubMed
-
- Cuspidi C, Macca G, Sampieri L, et al. Target organ damage and non‐dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens. 2001;19:1539‐1545. - PubMed
-
- Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422‐1428. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases